China Pharmaceutical Group said it will expand capacity and reduce unit costs by 5-30% to offset the impact of stiffer state price controls. The antibiotics and vitamin C maker said it has budgeted US$100 million this year to double annual production of its vitamin C product ï¿½ to 30,000 tonnes ï¿½ and its intermediate antibiotic product 7-ACA, to 1,600 tonnes. The company also said it will increase annual penicillin production to 8,000 tonnes by next year, too.
You must log in to post a comment.
Yes, I would like to receive emails from China Economic Review. (You can unsubscribe anytime)
Copyright © 2018 SinoMedia Group Limited All rights reserved